An Interview with Jennifer Brown About Idelalisib An Interview from the International Workshop on CLL with Jennifer Brown from the Dana Farber Cancer Institute Dr. Brian Koffman: Dr....
Biologic or Immunotherapies for Treatment of Chronic Lymphocytic Leukemia Take Away Points: Treatment with immunotherapies, particularly monoclonal antibodies (mAbs) have improved treatment outcomes in CLL. mAbs are more focused than chemotherapy,...
Chemotherapy for Chronic Lymphocytic Leukemia Take Away Points Chemotherapy used in chronic lymphocytic leukemia (CLL) mostly works by damaging the DNA of dividing cells. There are many...
Combination Therapies: Dr. Jennifer Brown Discusses the Evolving Treatment Paradigm for CLL Dr. Jennifer Brown from Dana-Farber in Boston discusses in this pithy, less than one minute long video the possible next...
Comments on Chemotherapy Take Away Points Chemotherapy may be part of the best treatment option for some patients. Clinical trials using chemotherapy will provide valuable...
Dr. Jeff Jones on the Importance of Genetic Testing Before Treating our CLL (chronic lymphocytic leukemia) or any cancer In this short but pithy news interview, Dr. Jeff Jones from Ohio State explains why it so very important to...
Frontline Therapy in Chronic Lymphocytic Leukemia (CLL) Treatment decision should always be individualized. One size does not fit all with chronic lymphocytic leukemia (CLL). The best therapeutic...
Immune Strategies in CLL Chronic lymphocytic leukemia (CLL) is characterized by a dysregulated immune system and the clinical course of CLL is dominated by...
Immunogobulins and IVIG CLL Horizons Meeting 2016 - An Interview with Dr. Ben Kennedy on Immunoglobulins in CLL CLL is a cancer of the...
New Formulation of Imbruvica (ibrutinib) – Commentary Dr. Furman has been involved in the development of ibrutinib since its very earliest trials. This discussion was triggered by the...
